Palliative Care for Parkinson's Disease
(COPE-PD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if training community doctors in palliative care and providing telemedicine support can improve the quality of life for individuals with Parkinson's disease or Lewy Body Dementia and their caregivers. Palliative care focuses on alleviating symptoms such as pain and depression while addressing emotional and spiritual needs. Participants will either receive the usual care from their neurologists or gain access to enhanced support through online services and trained doctors. This trial may suit those over 40 diagnosed with Parkinson's or similar conditions who are not already receiving palliative or hospice care. As an unphased trial, this study offers a unique opportunity to explore innovative care approaches that could significantly enhance participants' quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this palliative care training and telemedicine support are safe for patients with Parkinson's disease and related conditions?
Research has shown that training community neurologists in palliative care, combined with telehealth support, is generally safe and well-received. One study found that 95% of participants using telepalliative care services felt they received better care than with traditional methods. This indicates that the treatment is not only safe but also appreciated by users.
The treatment trains doctors to better support patients with Parkinson's disease and similar conditions through online methods, including support groups and educational resources. No significant reports of harm or negative effects have emerged from this approach.
Overall, the goal is to improve quality of life by addressing pain, depression, and other symptoms. This method uses technology to provide care without requiring in-person visits, which many find convenient and helpful.12345Why are researchers excited about this trial?
Researchers are excited about the Online Community-Supported Palliative Care for Parkinson's disease because it offers a new approach to managing symptoms and improving quality of life. Unlike traditional treatments that focus primarily on medication management and physical therapy, this intervention emphasizes training neurologists in palliative care through teleconferences, enhancing their ability to provide comprehensive care. Additionally, it provides patients and their caregivers access to online support groups and tailored educational resources, fostering a more holistic and supportive care environment. This innovative method has the potential to significantly enhance patient and caregiver experiences by integrating community resources and expert support into everyday care.
What evidence suggests that this trial's palliative care interventions could be effective for Parkinson's disease and related conditions?
Research has shown that training community neurologists in palliative care, combined with telemedicine support, can improve the quality of life for patients with Parkinson's disease and similar conditions. In this trial, some participants will receive Online Community-Supported Palliative Care. Neurologists will learn about palliative care and consult with a remote team, offering patients and their families additional support services. This approach enhances life quality and aids in planning future care. Telehealth, which provides healthcare services remotely, facilitates timely support and personalized information for patients and caregivers. Overall, these findings suggest that online community-supported palliative care could effectively assist those living with Parkinson's disease.12367
Who Is on the Research Team?
Benzi Kluger, MD
Principal Investigator
University of Rochester
Are You a Good Fit for This Trial?
This trial is for people over 40 with Parkinson's disease or related conditions like progressive supranuclear palsy, multiple system atrophy, and Lewy Body Dementia. It's not for those who can't commit to the study, need palliative care for other illnesses like advanced cancer, or are already receiving palliative or hospice care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Data Collection
Baseline data collection for usual care practices before intervention begins
Intervention
Community neurologists receive palliative care training and patients access online support services
Follow-up
Participants are monitored for quality of life and caregiver burden
What Are the Treatments Tested in This Trial?
Interventions
- Online Community-Supported Palliative Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
University of Colorado, Denver
Collaborator
Stanford University
Collaborator
Massachusetts General Hospital
Collaborator